Portage Biotech Inc. - Net Worth and Insider Trading
Portage Biotech Inc. Net Worth
The estimated net worth of Portage Biotech Inc. is at least $767,276 dollars as of 2025-05-04. Portage Biotech Inc. is the former 10% owner of Biohaven Pharmaceutical Holding Co Ltd and owns about 54,494 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $767,276. Details can be seen in Portage Biotech Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Portage Biotech Inc. has not made any transactions after 2018-01-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Portage Biotech Inc.
Portage Biotech Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Portage Biotech Inc. owns 1 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) .
Click here to see the complete history of Portage Biotech Inc.’s form 4 insider trades.
Insider Ownership Summary of Portage Biotech Inc.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2018-01-23 | 10 percent owner |
Portage Biotech Inc. Latest Holdings Summary
Portage Biotech Inc. currently owns a total of 1 stock. Portage Biotech Inc. owns 54,494 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of January 23, 2018, with a value of $767,276.
Latest Holdings of Portage Biotech Inc.
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | 2018-01-23 | 54,494 | 14.08 | 767,276 |
Holding Weightings of Portage Biotech Inc.
Portage Biotech Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Portage Biotech Inc. has made a total of 0 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the sale of 59,396 shares on January 23, 2018, which brought Portage Biotech Inc. around $8.0 Billion.
Insider Trading History of Portage Biotech Inc.
- 1
Portage Biotech Inc. Trading Performance
Portage Biotech Inc. Ownership Network
Ownership Network List of Portage Biotech Inc.
Ownership Network Relation of Portage Biotech Inc.
Portage Biotech Inc. Owned Company Details
What does Biohaven Pharmaceutical Holding Co Ltd do?
Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?
Portage Biotech Inc. is the 10 percent owner of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Medical Officer Elyse Stock , and Chief Financial Officer James Engelhart .
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biohaven Pharmaceutical Holding Co Ltd Insider Transactions
Portage Biotech Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Portage Biotech Inc.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Portage Biotech Inc.'s mailing address is: 6 Adelaide St. East Suite 300 Toronto A6 M5c 1h6.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
